摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(己氧基)-5-甲基苯胺 | 806600-79-3

中文名称
2-(己氧基)-5-甲基苯胺
中文别名
——
英文名称
2-hexyloxy-5-methyl-aniline
英文别名
2-Hexyloxy-5-methyl-anilin;2-(Hexyloxy)-5-methylaniline;2-hexoxy-5-methylaniline
2-(己氧基)-5-甲基苯胺化学式
CAS
806600-79-3
化学式
C13H21NO
mdl
——
分子量
207.316
InChiKey
KFUJHKDWGFKEKL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Norvaline Derivative and Method for Preparation Thereof
    申请人:Harada Naoyuki
    公开号:US20080076769A1
    公开(公告)日:2008-03-27
    Norvaline derivative of the formula [I] or pharmaceutically acceptable salt thereof, method for preparing the same, pharmaceutical composition containing the same, and use of said compound for inhibiting transporting activity of glycine transporter type 2 (GlyT2). [wherein X is —CH 2 —, —O—, —S— or single bond; Ar is optionally substituted aryl or lower cycloalkyl; n is 0 to 2; R 1 and R 2 are (i) each is hydrogen or lower alkyl; (ii) R 1 and R 2 are combined to form lower alkylene; or (iii) R 1 is hydrogen or lower alkyl and R 2 is combined with R 4 or R 6 to form lower alkylene; R 3 and R 4 are (i) each is hydrogen or lower alkyl; (ii) R 3 and R 4 are combined to form lower alkylene; or (iii) R 3 is hydrogen or lower alkyl and R 4 is combined with R 2 or R 6 to form lower alkylene; R is or —OR 7 ; R 5 and R 6 are (i) each is optionally substituted lower alkyl, or hydrogen; (ii) R 5 and R 6 are combined to form aliphatic 5- to 6-membered heterocyclic group; or (iii) R 5 is optionally substituted lower alkyl or hydrogen and R 6 is combined with R 2 or R 4 to form lower alkylene; R 7 is lower alkyl.
    Norvaline衍生物的化学式[I]或其药学上可接受的盐,制备方法,含有该化合物的药物组合物,以及用于抑制甘氨酸转运体2型(GlyT2)的转运活性的用途。[其中X为-CH2-,-O-,-S-或单键;Ar为可选取代芳基或较低的环烷基;n为0至2;R1和R2为(i)氢或较低的烷基;(ii)R1和R2结合形成较低的烷基;或(iii)R1为氢或较低的烷基,R2与R4或R6结合形成较低的烷基;R3和R4为(i)氢或较低的烷基;(ii)R3和R4结合形成较低的烷基;或(iii)R3为氢或较低的烷基,R4与R2或R6结合形成较低的烷基;R为-OH或-OR7;R5和R6为(i)可选取代的较低烷基或氢;(ii)R5和R6结合形成脂肪族5-至6-成员杂环基;或(iii)R5为可选取代的较低烷基或氢,R6与R2或R4结合形成较低的烷基;R7为较低烷基。
  • NORVALINE DERIVATIVE AND METHOD FOR PREPARATION THEREOF
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP1846366B1
    公开(公告)日:2011-08-03
  • US7718703B2
    申请人:——
    公开号:US7718703B2
    公开(公告)日:2010-05-18
查看更多